Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.46 |
| ▸ | LMNA | P02545 | 3/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 2/20 | 0.41 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | F2 | P00734 | 1/20 | 0.37 |
| ▸ | ELANE | P08246 | 1/20 | 0.37 |
| ▸ | CTSG | P08311 | 1/20 | 0.37 |
| ▸ | CMA1 | P23946 | 1/20 | 0.37 |
| ▸ | CTRC | Q99895 | 1/20 | 0.37 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | MGLL | Q99685 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL34870 | 0.98 | MAPT (0.44) | MAPTTDP1LMNANPSR1L3MBTL1 | |
| SCHEMBL28380433 | 0.89 | LMNA (0.31) | MAPTTDP1LMNANPSR1L3MBTL1 | |
| SCHEMBL14889034 | 0.78 | MAPT (0.42) | MAPTTDP1LMNANPSR1L3MBTL1 | |
| SCHEMBL13680338 | 0.78 | L3MBTL1 (0.42) | MAPTTDP1LMNANPSR1L3MBTL1 | |
| SCHEMBL5352313 | 0.77 | MAPT (0.42) | MAPTLMNANPSR1L3MBTL1HTT | |
| SCHEMBL21388452 | 0.76 | MAPT (0.41) | MAPTTDP1LMNANPSR1L3MBTL1 | |
| SCHEMBL223853 | 0.72 | MAPT (0.42) | MAPTTDP1LMNANPSR1L3MBTL1 | |
| SCHEMBL9668319 | 0.70 | MAPT (0.55) | MAPTTDP1LMNANPSR1L3MBTL1 | |
| Hydrochloric Acid SCHEMBL820585 | 0.70 | MAPT (0.41) | MAPTTDP1LMNANPSR1L3MBTL1 | |
| SCHEMBL13973362 | 0.70 | ALDH1A1 (0.39) | LMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 245 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3220942-B1 | COMPOSITIONS COMPRISING LOW DOSE DESMOPRESSIN IN COMBINATION WITH AN ALPHA-ADRENERGIC RECEPTOR ANTAGONIST | SERENITY PHARMACEUTICALS LLC (US) | 2022-04-27 | — | — | EP | claimed |
| EP-3485908-B1 | THERAPEUTIC COMBINATION AND USE OF DLL4 ANTAGONIST ANTIBODIES AND ANTI-HYPERTENSIVE AGENTS | MEREO BIOPHARMA 5 INC (US) | 2021-08-18 | — | — | EP | claimed |
| CN-112822948-A | TAAR receptor agonists for the treatment of alopecia | 应用生物学公司 | 2021-05-18 | — | — | CN | claimed |
| CN-112624975-A | Torazolidine hapten, artificial antigen, antibody, preparation and application thereof | 华南农业大学 | 2021-04-09 | — | — | CN | claimed |
| CN-111888325-A | Carrageenan gel, pharmaceutical excipient and skin external preparation | 瑞希(重庆)生物科技有限公司 | 2020-11-06 | — | — | CN | claimed |
| CN-111263758-A | Branched multifunctional macromers and related polymers and uses thereof | 麻省理工学院 | 2020-06-09 | — | — | CN | claimed |
| EP-2858649-B1 | TREATMENT OF MOTOR AND MOVEMENT DISORDER SIDE EFFECTS ASSOCIATED WITH PARKINSON'S DISEASE TREATMENTS | PSYCHOGENICS INC (US) | 2019-10-23 | — | — | EP | claimed |
| EP-2352543-B1 | METHODS AND COMPOSITIONS FOR TATTOO REMOVAL | BIOCHEMICS INC (US) | 2019-04-03 | — | — | EP | claimed |
| EP-2376074-B1 | METHOD FOR IMPROVED BIOACTIVATION OF MEDICATIONS | DRITTE PATENTPORTFOLIO BETEILI (DE) | 2019-03-13 | — | — | EP | claimed |
| EP-3072526-B1 | THERAPEUTIC COMBINATION AND USE OF DLL4 ANTAGONIST ANTIBODIES AND ANTI-HYPERTENSIVE AGENTS | ONCOMED PHARM INC (US) | 2018-09-26 | — | — | EP | claimed |
| EP-0517850-B1 | COMPOSITIONS AND METHODS OF TREATMENT OF SYMPATHETICALLY MAINTAINED PAIN | ARC 1 INC (US) | 2003-11-12 | — | — | EP | claimed |
| WO-2003074088-A2 | COUPLING LOW-MOLECULAR SUBSTANCES TO HYDROXYALKYL STARCH | BIOTECHNOLOGIE - GESELLSCHAFT MITTELHESSEN MBH (DE) | 2003-09-12 | — | — | WO | claimed |
| EP-1052993-B1 | COMBINATION OF AN ALPHA-ADRENERGIC ANTAGONIST AND A NITROGEN OXIDE DONOR FOR TREATING FEMALE SEXUAL DYSFUNCTION | MEDICAL & PHARMA DEV AND INVES (IE) | 2003-01-02 | — | — | EP | claimed |
| EP-1084569-A2 | PHARMACEUTICAL COMBINATIONS FOR COMPENSATING FOR A TESTOSTERONE DEFICIENCY IN MEN WHILE SIMULTANEOUSLY PROTECTING THE PROSTATE | Jenapharm GmbH & Co. KG (DE) | 2001-03-21 | — | — | EP | claimed |
| EP-0652768-B1 | A pharmaceutical preparation for the synergistic activation of natural killer cells | MAXIM PHARM INC (US) | 2000-05-03 | — | — | EP | claimed |
| WO-1999065228-A2 | PHARMACEUTICAL COMBINATION USED TO COMPENSATE FOR A TESTOSTERONE DEFICIENCY WHILE PROTECTING THE PROSTATE | JENAPHARM GMBH & CO. KG (DE) | 1999-12-16 | — | — | WO | claimed |
| EP-0714300-B1 | METHODS FOR MODULATING THE HUMAN SEXUAL RESPONSE | ZONAGEN INC (US) | 1998-12-23 | — | — | EP | claimed |
| EP-0617612-B1 | A PROCESS FOR THE PREPARATION OF A SOLID DISPERSION | WARNER LAMBERT CO (US) | 1997-09-10 | — | — | EP | claimed |
| EP-0449463-B1 | Method and composition for iontophoresis | BECTON DICKINSON CO (US) | 1994-11-30 | — | — | EP | claimed |
| EP-0007572-A1 | Pharmaceutical mixtures containing an amantadine compound | CIBA-GEIGY AG (CH) | 1980-02-06 | — | — | EP | claimed |